Pay-for-performance deals could be replacing rebate negotiations for medicines hinted a GKV-Spitzenverband (National Association of Statutory Health Insurance Funds) representative. … read more »
HAS has announced its new strategy over CAR-T cell treatments, revolving around reassessment and patient information. The safe, rapid and … read more »
Today has seen a busy final day of the World Advanced Therapies & Regenerative Medicine Congress 2019 in London. MAP … read more »
New research has discovered thousands of genes which are essential for cancer’s survival, bringing new potential possibilities for treatment. The … read more »
GSAV: What impact will it have on OMP registries in Germany? And how should those registries be designed?
As reported previously, the Federal Joint Committee (GBA) will likely request registry data for most orphan medicinal product (OMPs) launched in … read more »
The Federal Ministry of Health in Germany (BMG) has recently introduced a bill which intends to reform the risk-pool RSA … read more »